Compare Quanta Services Inc (PWR) vs Summit Therapeutics Inc (SMMT) Price & Performance

Quanta Services IncTrade

Summit Therapeutics IncTrade

Price performance (Past 24H)

Key statistics

Quanta Services Inc vs Summit Therapeutics Inc — how do they compare? Quanta Services Inc trades at $644.06 (market cap $95.92B), while Summit Therapeutics Inc trades at $14.78 (market cap $11.34B). The key difference: Quanta Services Inc is far larger — about 8.5× Summit Therapeutics Inc's market cap, and Quanta Services Inc pays a 0.07% dividend while Summit Therapeutics Inc pays none. Which is the better fit depends on your goals.

	PWR	SMMT
Market Cap	$95.92B	$11.34B
Sector	Industrials	Health
52-Week High	$785.24	$29.32
52-Week Low	$372.50	$13.05
Enterprise Value	$101.87B	$10.76B
Dividend Yield	0.07%	—

View details →View details →

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

PWR

Quanta named top US solar provider after installing 6,100 MW in 2025, leading the industry for 3 of 4 years.PRNewsWire · 1 day agoBullish Tortoise AI Infrastructure ETF offers diversified AI exposure with growth potential in power and data sectors.Seeking Alpha · 2 days agoBullish Quanta Services shifts to capacity brokerage, targeting high-value infrastructure growth with strong 2026 outlook.Seeking Alpha · 4 days agoBullish View details →

SMMT

Summit Therapeutics upgraded to Buy after FDA accepts BLA for lung cancer drug ivonescimab.Seeking Alpha · 9 hours agoBullish US extends zero tariffs on imported generic drugs for 2 years, boosting pharma stocks.Finbold · 18 hours agoBullish View details →

About Quanta Services Inc

Quanta Services is a leading provider of specialty contracting services, delivering comprehensive infrastructure solutions for the electric and gas utility, communications, pipeline, and energy industries in the United States, Canada, and Australia. Quanta reports its results under two reportable segments: electric power infrastructure solutions and underground utility and infrastructure solutions. In October 2021, the company completed the acquisition of Blattner, a provider of comprehensive engineering, procurement, and construction solutions to customers in the renewable energy industry.

About Summit Therapeutics Inc

Summit Therapeutics Inc. is a biopharmaceutical company focused on the development and commercialization of new medicines for the treatment of infectious diseases and other unmet medical needs. The company's lead product candidate is an antibiotic for the treatment of Clostridioides difficile infection (CDI), a serious infection of the colon. Summit Therapeutics is committed to bringing innovative therapies to market to address global health challenges and improve patient outcomes.